Akira Tokumura Selected Research

alpha-tocopheryl oxalate

5/2004

Structural characteristic of terminal dicarboxylic moiety required for apoptogenic activity of alpha-tocopheryl esters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akira Tokumura Research Topics

Disease

15	Neoplasms (Cancer) 01/2017 - 01/2002
5	Stomach Ulcer (Gastric Ulcer) 01/2018 - 08/2011
3	Body Weight (Weight, Body) 11/2018 - 04/2013
3	Fibrosis (Cirrhosis) 01/2015 - 08/2011
3	Atherosclerosis 05/2010 - 02/2002
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2017
2	Periodontitis 09/2020 - 01/2020
2	Alveolar Bone Loss 09/2020 - 01/2020
2	Carcinoma (Carcinomatosis) 03/2018 - 01/2002
2	Ovarian Neoplasms (Ovarian Cancer) 04/2007 - 05/2002
2	Melanoma (Melanoma, Malignant) 12/2005 - 03/2003
1	Hypoxia (Hypoxemia) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Carcinogenesis 01/2017
1	Peptic Ulcer (Peptic Ulcers) 09/2016
1	Inflammation (Inflammations) 05/2014
1	Pruritus (Itching) 05/2014
1	Atopic Dermatitis (Atopic Eczema) 05/2014
1	Renal Insufficiency (Renal Failure) 03/2014
1	Necrosis 01/2014
1	Diarrhea 04/2012
1	Corneal Injuries 03/2012
1	Wounds and Injuries (Trauma) 03/2012
1	Ulcer 08/2011
1	Ureteral Obstruction 08/2011
1	Systemic Scleroderma (Systemic Sclerosis) 06/2009
1	Breast Neoplasms (Breast Cancer) 05/2004
1	Atherosclerotic Plaque (Atheroma) 11/2003
1	Glioma (Gliomas) 06/2002

Drug/Important Bio-Agent (IBA)

16	lysophosphatidic acidIBA 09/2020 - 01/2002
9	alkylglycerophosphoethanolamine phosphodiesteraseIBA 05/2014 - 01/2002
8	Phospholipids (Phosphatides)FDA LinkGeneric 01/2017 - 01/2002
6	LysophospholipidsIBA 03/2018 - 08/2011
4	LipidsIBA 01/2018 - 11/2003
4	Proteins (Proteins, Gene)FDA Link 05/2014 - 04/2007
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
3	Phospholipases (Phospholipase)IBA 01/2022 - 09/2012
3	EnzymesIBA 07/2016 - 01/2002
2	Lysophospholipase (Phospholipase B)IBA 09/2020 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 11/2018 - 04/2013
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2018 - 09/2016
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 09/2016
2	aristolochic acid I (aristolochic acid)IBA 07/2016 - 01/2015
2	Lysophosphatidic Acid ReceptorsIBA 05/2014 - 06/2002
2	MetalsIBA 03/2014 - 04/2007
2	AcyltransferasesIBA 12/2013 - 09/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2012 - 01/2002
2	Biological ProductsIBA 03/2012 - 06/2002
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 08/2011 - 11/2003
2	Succinic Acid (Succinate)IBA 12/2005 - 05/2004
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	choline plasmalogensIBA 01/2022
1	PlasmalogensIBA 01/2022
1	lysoplasmalogenase (alkenylglycerophosphocholine hydrolase)IBA 01/2022
1	phosphatidal ethanolaminesIBA 01/2022
1	Butyric Acid (Butanoic Acid)IBA 03/2018
1	PowdersIBA 01/2018
1	peony root extractIBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Dextrans (Dextran)FDA Link 01/2017
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017
1	AzoxymethaneIBA 01/2017
1	Protective AgentsIBA 09/2016
1	Phosphatidic Acids (Phosphatidic Acid)IBA 09/2016
1	SaltsIBA 07/2016
1	lysophosphatidylinositolIBA 01/2015
1	lysophosphatidylserineIBA 01/2015
1	Opioid Analgesics (Opioids)IBA 05/2014
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 05/2014
1	CadmiumIBA 03/2014
1	Hyaluronan ReceptorsIBA 01/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2013
1	Nonesterified Fatty Acids (NEFA)IBA 04/2013
1	Pharmaceutical PreparationsIBA 04/2013
1	DiglyceridesIBA 04/2013
1	LecithinsIBA 08/2011
1	SolutionsIBA 08/2011
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 06/2009
1	OxalatesIBA 12/2005
1	malonic acid (malonate)IBA 12/2005
1	alpha-Tocopherol FDA Link 05/2004
1	alpha-tocopheryl malonateIBA 05/2004
1	EstersIBA 05/2004
1	alpha-tocopheryl nicotinateIBA 05/2004
1	gamma-TocopherolIBA 05/2004
1	alpha-tocopheryl oxalateIBA 05/2004
1	Platelet Activating FactorIBA 11/2003
1	oxidized low density lipoproteinIBA 11/2003
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2003
1	Free RadicalsIBA 12/2002
1	Superoxides (Superoxide)IBA 12/2002
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2002
1	nucleotide pyrophosphataseIBA 10/2002
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 10/2002
1	2-arachidonoyl-sn-glycero-3-phosphateIBA 06/2002

Therapy/Procedure

2	Oral Administration 01/2017 - 04/2013
2	Intravenous Administration 12/2005 - 03/2003
1	Ligation 01/2020
1	Intraperitoneal Injections 01/2015
1	Intradermal Injections 05/2014